As our understanding of the human genome expands, so does the desire to translate this knowledge into effective clinical tools. With a growing number of complex genomic tests for biomarker signatures becoming commercially available, the promise of personalized medicine is fast becoming a reality. Although researchers and clinicians are continuously striving to enable quicker and more individualized treatment decisions, the development of these tests is a long road, with discovery and validation of genomic biomarker signatures just the start. Our expert panel will discuss the practicalities of developing a test from signature discovery and validation all the way to clinic.
During the webinar, topics discussed will include:
• Considerations for developing a robust, clinically relevant test
• Practicalities of clinical trials, such as sample size and availability considerations
• Navigating the regulatory approval process.
You’ll also have the opportunity to ask questions of the panelists during the live Q&A session.
For more information on products/technologies related to this webinar, go to: www.affymetrix.com/pba_partners